Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rintaro Hashizume

Showing results (21-30 of 85) with videos related to

Pageof 9
Sort By:
Journal of Neuro-Oncology|July 9, 2009
A human brainstem glioma xenograft model enabled for bioluminescence imagingRintaro Hashizume, Tomoko Ozawa, Eduard B Dinca, et al.
Acta Neuropathologica Communications|April 9, 2022
A tumor suppressor role for EZH2 in diffuse midline glioma pathogenesisSwati Dhar, Samantha Gadd, Priyam Patel, et al.
Neuro-Oncology|February 22, 2008
New therapeutic approach for brain tumors: Intranasal delivery of telomerase inhibitor GRN163Rintaro Hashizume, Tomoko Ozawa, Sergei M Gryaznov, et al.
Cancers|July 14, 2023
WDR82-Mediated H3K4me3 Is Associated with Tumor Proliferation and Therapeutic Efficacy in Pediatric High-Grade GliomasNitin Wadhwani, Sonali Nayak, Yufen Wang, et al.
Neuro-Oncology|March 24, 2010
Morphologic and molecular characterization of ATRT xenografts adapted for orthotopic therapeutic testingRintaro Hashizume, Nalin Gupta, Mitchel S Berger, et al.
Neuro-Oncology Advances|August 4, 2021
The effects of palbociclib in combination with radiation in preclinical models of aggressive meningiomaCraig Horbinski, Guifa Xi, Yufen Wang, et al.
Journal of Neuro-Oncology|November 25, 2017
New therapeutic approaches for brainstem tumors: a comparison of delivery routes using nanoliposomal irinotecan in an animal modelNundia Louis, Sharon Liu, Xingyao He, et al.
Frontiers in Oncology|February 11, 2020
MGMT Expression Contributes to Temozolomide Resistance in H3K27M-Mutant Diffuse Midline GliomasHideaki Abe, Manabu Natsumeda, Masayasu Okada, et al.
Molecular Cancer Research : MCR|May 20, 2017
Histone H3.3K27M Represses <i>p16</i> to Accelerate Gliomagenesis in a Murine Model of DIPGFrancisco J Cordero, Zhiqing Huang, Carole Grenier, et al.
Journal of Neuro-Oncology|May 7, 2026
Human neural organoid modeling of diffuse midline glioma captures the complexity of patient tumorsJack M Shireman, Elliot Xie, Connie S Lebakken, et al.
Pageof 9

Showing results (21-30 of 85) with videos related to

Sort By:
Pageof 9
Journal of Neuro-Oncology|July 9, 2009
A human brainstem glioma xenograft model enabled for bioluminescence imagingRintaro Hashizume, Tomoko Ozawa, Eduard B Dinca, et al.
Acta Neuropathologica Communications|April 9, 2022
A tumor suppressor role for EZH2 in diffuse midline glioma pathogenesisSwati Dhar, Samantha Gadd, Priyam Patel, et al.
Neuro-Oncology|February 22, 2008
New therapeutic approach for brain tumors: Intranasal delivery of telomerase inhibitor GRN163Rintaro Hashizume, Tomoko Ozawa, Sergei M Gryaznov, et al.
Cancers|July 14, 2023
WDR82-Mediated H3K4me3 Is Associated with Tumor Proliferation and Therapeutic Efficacy in Pediatric High-Grade GliomasNitin Wadhwani, Sonali Nayak, Yufen Wang, et al.
Neuro-Oncology|March 24, 2010
Morphologic and molecular characterization of ATRT xenografts adapted for orthotopic therapeutic testingRintaro Hashizume, Nalin Gupta, Mitchel S Berger, et al.
Neuro-Oncology Advances|August 4, 2021
The effects of palbociclib in combination with radiation in preclinical models of aggressive meningiomaCraig Horbinski, Guifa Xi, Yufen Wang, et al.
Journal of Neuro-Oncology|November 25, 2017
New therapeutic approaches for brainstem tumors: a comparison of delivery routes using nanoliposomal irinotecan in an animal modelNundia Louis, Sharon Liu, Xingyao He, et al.
Frontiers in Oncology|February 11, 2020
MGMT Expression Contributes to Temozolomide Resistance in H3K27M-Mutant Diffuse Midline GliomasHideaki Abe, Manabu Natsumeda, Masayasu Okada, et al.
Molecular Cancer Research : MCR|May 20, 2017
Histone H3.3K27M Represses <i>p16</i> to Accelerate Gliomagenesis in a Murine Model of DIPGFrancisco J Cordero, Zhiqing Huang, Carole Grenier, et al.
Journal of Neuro-Oncology|May 7, 2026
Human neural organoid modeling of diffuse midline glioma captures the complexity of patient tumorsJack M Shireman, Elliot Xie, Connie S Lebakken, et al.
Pageof 9